APA (7th ed.) Citation

Linge, A., Lohaus, F., Löck, S., Nowak, A., Gudziol, V., Valentini, C., . . . Baumann, M. (2016). HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiotherapy and oncology, 121(3), . https://doi.org/10.1016/j.radonc.2016.11.008

Chicago Style (17th ed.) Citation

Linge, Annett, et al. "HPV Status, Cancer Stem Cell Marker Expression, Hypoxia Gene Signatures and Tumour Volume Identify Good Prognosis Subgroups in Patients with HNSCC After Primary Radiochemotherapy: A Multicentre Retrospective Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)." Radiotherapy and Oncology 121, no. 3 (2016). https://doi.org/10.1016/j.radonc.2016.11.008.

MLA (9th ed.) Citation

Linge, Annett, et al. "HPV Status, Cancer Stem Cell Marker Expression, Hypoxia Gene Signatures and Tumour Volume Identify Good Prognosis Subgroups in Patients with HNSCC After Primary Radiochemotherapy: A Multicentre Retrospective Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)." Radiotherapy and Oncology, vol. 121, no. 3, 2016, https://doi.org/10.1016/j.radonc.2016.11.008.